Intravesical Chemotherapy Flashcards

1
Q

How many instillations are given immediately post op?

A

Single installation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Within how many hours should you give intravesical therapy post TURBT?

A

24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Within how many hours is the more ideal time to give intravesical chemotherapy post TURBT?

A

Within 6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the rationale in giving immediate intravesical therapy post TURBT? Give two reasons.

A

To prevent implantation of cancer cells. To prevent early recurrence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Does immediate intravesical therapy post TURBT decrease the risk of recurrence? By how much?

A

Yes. By 35%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Does immediate intravesical therapy post TURBT prolong the time of progression or time to death from bladder cancer?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If patients with previous recurrences had repeat TURBT, does immediate intravesical therapy post repeat TURBT still reduce recurrences?

A

Not anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In patients with EORTC recurrence score of 5 or more, will immediate intravesical therapy post TURBT decrease the risk of recurrence?

A

Not anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In patients with 8 or more tumors, does immediate postop intravesical chemotherapy reduce recurrence?

A

Not anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Does immediate postop intravesical chemotherapy reduce the risk of progression or the risk of cancer mortality?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 2 most commonly used agents for intravesical chemotherapy?

A

Gemcitabine and Mitomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which of the two agents is preferred for intravesical chemotherapy

A

Gemcitabine is preferred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give two conditions why it is the preferred agent?

A

Better toxicity profile and better cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the contraindications for giving immediate intravesical chemotherapy?

A

Perforation, allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give the three most commonly used agents. (Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Gemcitabine, mitomycin, BCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which patients should be prioritized for induction intravesical chemotherapy when there is BCG shortage?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

high risk patients (high grade T1, Tis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which agents are preferable alternatives to BCG?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Mitomycin and gemcitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Give other options for induction intravesical chemotherapy aside from the three most commonly used agents. (Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Epirubicin Valrubicin Sequential Gemcitabine/Docetaxel Sequential Gemcitabine/mitomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Is sequential intravesical chemotherapy an option? (Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the TWO sequential intravesical chemotherapy options available?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Gemcitabine/Docetaxel and Gemcitabine/Mitomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the split dose options for BCG used in times of shortage?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

1/2 and 1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When will you initiate induction intravesical chemotherapy or BCG post TURBT?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

3-4 weeks post TURBT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Instillations are given on a _______ basis for ________ weeks.(Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

Given on a weekly basis for 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How many consecutive cycle inductions are given at a maximum if there is no complete response? (Induction (Adjuvant) Intravesical Chemotherapy or BCG)

A

2 consecutive cycle inductions

25
Give conditions to withhold induction intravesical treatment?(Induction (Adjuvant) Intravesical Chemotherapy or BCG)
Traumatic catheterization, bacteriuria, allergy, severe and persistent local and systemic symptoms, immunocompromised, persistent gross hematuria
26
What regimen is being followed by the NCCN Member Institutions for BCG maintenance therapy?
SWOG
27
This consists of a \_\_\_\_\_\_\_\_-week induction course of BCG and how many weekly instillations?
Six week induction course of BCG, and 3 weekly installations
28
The abovementioned weekly instillations are given at what months? (7 month answers)
3,6,9, 12,18,24,30,36
29
When there is BCG shortage, which patients are prioritized?
High risk patients (high grade T1 and CIS)
30
When there is BCG shortage, in prioritized patients, which are the most crucial months in the maintenance period?
3rd month and 6th month
31
For intermediate risk patients, how long should maintenance BCG therapy be given?
1 year
32
For high risk NMIBC, how long should maintenance BCG therapy be given?
3 years
33
Is dose reduction an option in patients receiving maintenance intravesical BCG?
yes
34
What are the conditions for dose reductions in patients receiving maintenance intravesical BCG?
Substanial local symptoms during therapy
35
Is there data to support decreased rate of recurrence for NMIBC in patients receiving maintenance intravesical BCG?
Yes
36
How are topical chemotherapeutic agents delivered?
By instillation
37
What are the approaches used in delivering the agents? (Topical or Percutaneous Administration of Chemotherapy and BCG)
Antegrade or retrograde (NT or ureteral stent)
38
Is there a standard regimen? (Topical or Percutaneous Administration of Chemotherapy and BCG)
No standard regimen
39
Which particular components of the prostate are involved when one is considering post-surgical intraurethral therapy for primary carcinoma of the prostate?
Ductal + Acinar and Prostatic Urethra
40
When is the induction therapy initiated post TURP? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Prostate)
3-4 weeks post TURP
41
What follows post induction therapy? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Prostate)
Maintenance BCG
42
Does data indicate a reduction in the recurrence in the prostate in patients with superficial disease?
YES
43
Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Urethra is considered a primary treatment with what stages of the disease?
Ta, T1, Tis
44
When is induction therapy initiated? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Urethra)
3-4 weeks after TUR
45
Which 3 agents are most commonly used? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Urethra)
Gemcitabine, Mitomycin, BCG
46
Is there a role in doing maintenance intravesical chemotherapy or BCG in this context? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Urethra)
Uncertain
47
Is the efficacy of this method established? (Post-Surgical Intraurethral Therapy for Primary Carcinoma of the Urethra)
No
48
What is a recommended requirement prior to initiating intrapelvic/intravesical therapy for UTT?
Complete or near complete endoscopic resection or ablation
49
What agent is available for intrapelvic/intravesical therapy for UTT? In what form?
Mitomycin gel form!
50
What are the FOUR suitable indications for intrapelvic/intravesical therapy for UTT?
Low grade Low volume (5-15mm) Solitary Tumor Not a candidate for nephroureterectomy
51
How is the available agent to be administered? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Primary Therapy)
via ureteral cathater or a nephrostomy tube
52
What are the TWO FEATURES of patients who are candidates for intrapelvic therapy? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
Non metastatic and low grade tumors
53
When is induction adjuvant therapy initiated after endoscopic resection? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
3-4 weeks after endoscopic resection
54
What are the most commonly used agents for intrapelvic therapy? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
BCG, Mitomycin, and Gemcitabine
55
Is there a role for maintenance following intrapelvic therapy? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
UNCERTAIN
56
Is efficacy of intrapelvic therapy in upper urinary tract cancers already been established? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
NO
57
Is there a role for perioperative intravesical chemotherapy following nephroureterctomy with cuff of bladder resection? (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
YES
58
Which agents are given if there is a role for perioperative intravesical chemotherapy. (Intrapelvic and Intravesical Therapy for Upper Tract Tumors Postsurgical Therapy)
Mitomycin or Gemcitabine